A landmark study led by the Wellcome Sanger Institute has fundamentally altered the scientific understanding of how chronic myeloid leukemia…
Read More
TWiV 1284: Clinical Update with Dr. Daniel Griffin
In a recent episode of "This Week in Virology" (TWiV), recorded shortly after the New Year’s transition, host Vincent Racaniello…
Read More
TWiV 1286: Clinical Update with Dr. Daniel Griffin
In a recent clinical update hosted by This Week in Virology (TWiV), Dr. Daniel Griffin and Vincent Racaniello expressed profound…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – A novel drug candidate for glioblastoma, KTM-101, developed by researchers at the University of California, Los…
Read More
Decoding Legal Trends and Emerging Considerations in Laboratory Data with a Focus on Value, Clarifying Ownership and Access Rights, Protecting Data, and Strategically Monetizing Information
Cleveland, OH – In a significant event for the legal and business communities, Elizabeth Sullivan, JD, and Emily Johnson, JD,…
Read More
NYU Langone Health Leaders Unveil Visionary Strides in Digital Pathology, Revolutionizing Diagnostic Services and Patient Care
In a landmark presentation that underscored the transformative potential of advanced medical technology, Christina Baranetsky, Senior Administrative Director of Pathology…
Read More
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform
A groundbreaking study, commissioned by eClinical Solutions and modeled by Hobson & Company, has unveiled compelling evidence of the transformative…
Read More
TWiV 1288: Clinical update with Dr. Daniel Griffin
In a recent clinical update, Dr. Daniel Griffin, alongside Vincent Racaniello of This Week in Virology (TWiV), expressed significant concern…
Read More
TWiV 1290: Clinical update with Dr. Daniel Griffin
In a comprehensive clinical update delivered on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin provided insights into…
Read More
Immunai’s Digital "Plumbing" Secures Third Expansion with AstraZeneca, Deepening AI Integration Across Clinical Pipeline
Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced its third significant…
Read MoreYOU MAY HAVE MISSED
